Continuous Manufacturing Centers Of Excellence Measure Resurfaces In US House
Executive Summary
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
You may also be interested in...
Continuous Pharmaceutical Manufacturing Bill Hitches A Ride With US FDA User Fee Legislation
US legislation could advance new manufacturing platforms for drugs and biologics with academic R&D and workforce development and in turn spur domestic growth.
Continuous Manufacturing Back In Second Act
House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.
Generic Firms Want Congress To Build On CARES Act To Prevent Critical Drug Shortages
The association for manufacturers of generics and biologics calls for public sector investment in priority medicines.